India], March 11: Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with First Ladies of Africa and ...
The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...
Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug ...
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...
This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital ...
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...
Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis Europe and will lead the Company as it advances pioneering kidney disease ...
UK-based Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, today ...
Celonic Group, a Swiss-Based Quality CDMO, is integrating Merck’s Breez micro-bioreactor platform into its process ...